# David E. Neal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-e-neal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,276 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 123 |
| i10-index | 580 |
| OpenAlex ID | https://openalex.org/A5090783984 |
| ORCID iD | https://orcid.org/0000-0002-6033-5086 |
| Works | 1,282 |

## Researcher papers

- [10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer](https://scholariq.org/papers/10-year-outcomes-after-monitoring-surgery-or-radiotherapy-for-localized-prostate/)
- [Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer](https://scholariq.org/papers/patient-reported-outcomes-after-monitoring-surgery-or-radiotherapy-for-prostate/)
- [Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci](https://scholariq.org/papers/association-analyses-of-more-than-140-000-men-identify-63-new-prostate-cancer/)
- [Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer](https://scholariq.org/papers/fifteen-year-outcomes-after-monitoring-surgery-or-radiotherapy-for-prostate/)
- [Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction](https://scholariq.org/papers/trans-ancestry-genome-wide-association-meta-analysis-of-prostate-cancer/)
- [Spatial genomic heterogeneity within localized, multifocal prostate cancer](https://scholariq.org/papers/spatial-genomic-heterogeneity-within-localized-multifocal-prostate-cancer/)
- [The epidermal growth factor receptor and the prognosis of bladder cancer](https://scholariq.org/papers/the-epidermal-growth-factor-receptor-and-the-prognosis-of-bladder-cancer/)
- [Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.](https://scholariq.org/papers/systematic-review-and-economic-modelling-of-the-relative-clinical-benefit-and/)
- [Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts](https://scholariq.org/papers/polygenic-hazard-score-to-guide-screening-for-aggressive-prostate-cancer/)
- [Symptoms, unmet needs, psychological well‐being and health status in survivors of prostate cancer: implications for redesigning follow‐up](https://scholariq.org/papers/symptoms-unmet-needs-psychological-well-being-and-health-status-in-survivors-of/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research-2/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.